This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 Oct-Dec;9(4):471-7.

doi: 10.1016/0738-081x(91)90075-v.

Ciclopirox olamine: a hydroxypyridone antifungal agent

B B Abrams¹, H Hänel, T Hoehler

Affiliations

PMID: 1822407
DOI: 10.1016/0738-081x(91)90075-v

Review

Ciclopirox olamine: a hydroxypyridone antifungal agent

B B Abrams et al. Clin Dermatol. 1991 Oct-Dec.

. 1991 Oct-Dec;9(4):471-7.

doi: 10.1016/0738-081x(91)90075-v.

Authors

B B Abrams¹, H Hänel, T Hoehler

Affiliation

¹ Department of Clinical Research, Hoechst-Roussel Pharmaceuticals Inc., Somerville, NJ 08876-1258.

PMID: 1822407
DOI: 10.1016/0738-081x(91)90075-v

No abstract available

PubMed Disclaimer

Similar articles

Ciclopirox: an overview.
Gupta AK. Gupta AK. Int J Dermatol. 2001 May;40(5):305-10. doi: 10.1046/j.1365-4362.2001.01156.x. Int J Dermatol. 2001. PMID: 11554991 Review. No abstract available.
Ciclopirox for the treatment of superficial fungal infections: a review.
Gupta AK, Skinner AR. Gupta AK, et al. Int J Dermatol. 2003 Sep;42 Suppl 1:3-9. doi: 10.1046/j.1365-4362.42.s1.2.x. Int J Dermatol. 2003. PMID: 12895181 Review.
Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.
Jue SG, Dawson GW, Brogden RN. Jue SG, et al. Drugs. 1985 Apr;29(4):330-41. doi: 10.2165/00003495-198529040-00002. Drugs. 1985. PMID: 3158508 Review.
The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy.
Weir SJ, Patton L, Castle K, Rajewski L, Kasper J, Schimmer AD. Weir SJ, et al. J Clin Pharm Ther. 2011 Apr;36(2):128-34. doi: 10.1111/j.1365-2710.2010.01172.x. Epub 2010 Aug 24. J Clin Pharm Ther. 2011. PMID: 21366640
The dermatopharmacologic profile of ciclopirox 8% nail lacquer.
Bohn M, Kraemer K. Bohn M, et al. J Am Podiatr Med Assoc. 2000 Nov-Dec;90(10):491-4. doi: 10.7547/87507315-90-10-491. J Am Podiatr Med Assoc. 2000. PMID: 11107709

See all similar articles

Cited by

Candida albicans-The Virulence Factors and Clinical Manifestations of Infection.
Talapko J, Juzbašić M, Matijević T, Pustijanac E, Bekić S, Kotris I, Škrlec I. Talapko J, et al. J Fungi (Basel). 2021 Jan 22;7(2):79. doi: 10.3390/jof7020079. J Fungi (Basel). 2021. PMID: 33499276 Free PMC article. Review.
Computer-aided drug repurposing & discovery for Hepatitis B capsid protein.
Mohebbi A, Nabavi SPT, Naderi M, Sharifian K, Behnezhad F, Mohebbi M, Gholami A, Askari FS, Mirarab A, Monavari SH. Mohebbi A, et al. In Silico Pharmacol. 2025 Feb 25;13(1):35. doi: 10.1007/s40203-025-00314-8. eCollection 2025. In Silico Pharmacol. 2025. PMID: 40018383
Antifungal drug ciclopirox olamine reduces HSV-1 replication and disease in mice.
Bernier KM, Morrison LA. Bernier KM, et al. Antiviral Res. 2018 Aug;156:102-106. doi: 10.1016/j.antiviral.2018.06.010. Epub 2018 Jun 15. Antiviral Res. 2018. PMID: 29908958 Free PMC article.
Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors.
Niewerth M, Kunze D, Seibold M, Schaller M, Korting HC, Hube B. Niewerth M, et al. Antimicrob Agents Chemother. 2003 Jun;47(6):1805-17. doi: 10.1128/AAC.47.6.1805-1817.2003. Antimicrob Agents Chemother. 2003. PMID: 12760852 Free PMC article.
A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study.
Mohebbi A, Ghorbanzadeh T, Naderifar S, Khalaj F, Askari FS, Sammak AS. Mohebbi A, et al. PLoS One. 2023 May 17;18(5):e0285941. doi: 10.1371/journal.pone.0285941. eCollection 2023. PLoS One. 2023. PMID: 37196004 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database